Nanjing Medical Focuses On Medical Trust
This article was originally published in PharmAsia News
Executive Summary
Nanjing Medical Co. Ltd. (NMC) and Nanjing Medical Group have transferred 66 percent of their combined share in NMC Baixin Pharmacy Co., Ltd. to subsidiary Nanjing Pharmaceutical Co., Ltd. The move seeks to consolidate resources for an integrated procurement and supply chain, enabling Nanjing Medical to maximize its business network and increase sales. NMC is also selling out its 30 percent share in Nanjing MeiRui Pharma Co. Ltd. to the latter's U.S. parent company Cal-Nan Horizon Quest, Inc. Analysts believe the divestment allows NMC to focus on its core business of medical trust. The company aims to increase its trust business from the current 500 million yuan to 1 billion yuan in 2008. (Click here for more - Chinese Language)